This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Farmak, A.s.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Barbora Dvorakova: Innovator in Myocardial Imaging
Introduction
Barbora Dvorakova is a notable inventor based in Most, Czech Republic. She has made significant contributions to the field of myocardial imaging through her innovative work. Her research focuses on the development of a selective A2A adenosine receptor agonist, which has important implications for medical imaging.
Latest Patents
Barbora Dvorakova holds 1 patent for her invention related to a compound known as 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine. This compound is characterized as a selective A2A adenosine receptor agonist, which plays a crucial role in myocardial imaging. The invention includes a new polymorph of this compound, designated as polymorph E, which is defined by specific X-ray diffraction patterns and thermal characteristics. The method of preparing this polymorph involves recrystallization from other forms of the compound, utilizing a series of precise operations.
Career Highlights
Barbora Dvorakova is currently employed at Farmak, a.s., where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the understanding and application of adenosine receptor agonists in medical imaging.
Collaborations
Throughout her career, Barbora has collaborated with esteemed colleagues such as Lubomir Kvapil and Pavel Hradil. These partnerships have contributed to the success and impact of her research.
Conclusion
Barbora Dvorakova is a pioneering inventor whose work in myocardial imaging is shaping the future of medical diagnostics. Her innovative approaches and collaborations highlight her commitment to advancing healthcare technology.